Skip to main content

Find Clinical Trials

Home
Conditions
Connective Tissue Diseases

Clinical trial condition

Connective Tissue Diseases

Explore clinical trials studying Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

5,765 public trials 884 recruiting studies

Refine in advanced search Browse all conditions

Connective Tissue Diseases trial results

Completed

Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties

NCT05027152

Conditions: Behavior, Connective Tissue Diseases, Dermatomyositis, +10 more
Locations: Samira Tatiyama Miyamoto, PhD Vitória, Espírito Santo, Brazil

View Trial Details

Completed

Effects of SARAH Protocol in Women With Rheumatoid Arthritis

NCT05375422

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations: Samira Tatiyama Miyamoto, PhD Vitória, Espírito Santo, Brazil

View Trial Details

Completed

Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.

NCT06150651

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: King Chulalongkorn Memorial Hospital Bangkok, Please Select, Thailand

View Trial Details

Completed

Aerobic Exercise in Primary Sjögren's Syndrome

NCT02370225

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +17 more
Locations: Samira Tatiyama Miyamoto Vitória, Espírito Santo, Brazil

View Trial Details

Completed

Treatment Tapering in JIA With Inactive Disease

NCT02840175

Conditions: Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +7 more
Locations: Necker Children's Hospital Paris, France

View Trial Details

Completed

Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry

NCT01729455

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Glendale, Arizona, United States

GSK Investigational Site Goodyear, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

View all 179 locations

View Trial Details

Completed

Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus

NCT03920267

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: Local Institution - 0077 Birmingham, Alabama, United States

Local Institution - 0030 El Cajon, California, United States

Local Institution - 0049 Torrance, California, United States

Local Institution - 0074 New Haven, Connecticut, United States

View all 98 locations

View Trial Details

Completed

Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus

NCT00582881

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +5 more
Locations: University of Miami Miller School of Medicine Miami, Florida, United States

View Trial Details

Completed

Transition to Adulthood Through Coaching and Empowerment

NCT05570617

Conditions: Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +12 more
Locations: McMaster Children's Hospital Hamilton, Ontario, Canada

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia

NCT06164951

Conditions: Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations: QED Investigative Site San Francisco, California, United States

QED Investigative Site Aurora, Colorado, United States

QED Investigative Site Baltimore, Maryland, United States

QED Investigative Site Columbia, Missouri, United States

View all 27 locations

View Trial Details